Junshi Biosciences Announces Submission of a Marketing Authorization Application to the European Medicines Agency for Toripalimab
–The MAA was submitted in the EU for toripalimab seeking indications for the 1st line treatment of NPC and the 1st line treatment of ESCC — The global commercialization plan for toripalimab has expanded from China to the US and now, the EU SHANGHAI, China, Nov. 15, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., […]